Both in Pharmaceuticals
Faeth Therapeutics vs Climb Bio
Over the past year FTH returned −46.6% and CLYM returned −34.5%; their daily moves had a correlation of 0.52.
FTH −46.6% CLYM −34.5%Growth of $1, one year, split-adjusted
| Metric | FTH | CLYM |
|---|---|---|
| Price | $19.99 | $9.33 |
| Market cap | $516.6M | $535.9M |
| Today | +1.73% | −4.31% |
| 1 month | −25.7% | −12.6% |
| 6 months | — | −23.6% |
| Year to date | — | +133.3% |
| 1 year | — | +366.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.8M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 80.8% |
| Short % of float | 20.5% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).